CIK 0001087294 · Non-accelerated filer<br>Smaller reporting company
CUMBERLAND PHARMACEUTICALS INC
Sign in to watch- Ticker
- CPIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- TN
- Entity type
- operating
- EIN
- 621765329
- Phone
- 615-255-0068
- Business address
- 1600 WEST END AVENUE, SUITE 1300, NASHVILLE,, TN, 37203
- 4 Other acquisition Director acquired 1,093 shares (code L)
- 4 Other acquisition Director acquired 1,093 shares (code L)
- 4 Other acquisition Director acquired 2,800 shares (code L)
- 4 Other acquisition Chairman and CEO acquired 1,093 shares (code L)
- 4 Other acquisition Director acquired 2,672 shares (code L)
- 4 Other acquisition Director acquired 3,739 shares (code L)
- 4 Other acquisition Director acquired 747 shares (code L)
- 4 Other acquisition Director acquired 747 shares (code L)
- 4 Other acquisition Chairman and CEO acquired 747 shares (code L)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 1,000 shares (grant or award)
- 4 Grant or award Director acquired 1,000 shares (grant or award)
- 4 Grant or award Director acquired 1,000 shares (grant or award)
- 4 Grant or award Director acquired 1,000 shares (grant or award)
- 4 Grant or award Director acquired 5,000 shares (grant or award)
- 4 Other disposition Director disposed of 5,000 shares (other)
Page 7 of 26 · 512 filings